Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	3 mg Donepezil Hydrochloride	35
Overall Study	STARTED	5 mg Donepezil Hydrochloride	33
Overall Study	STARTED	10 mg Donepezil Hydrochloride	37
Overall Study	STARTED	Placebo	34
Overall Study	COMPLETED	3 mg Donepezil Hydrochloride	31
Overall Study	COMPLETED	5 mg Donepezil Hydrochloride	31
Overall Study	COMPLETED	10 mg Donepezil Hydrochloride	31
Overall Study	COMPLETED	Placebo	30
Overall Study	NOT COMPLETED	3 mg Donepezil Hydrochloride	4
Overall Study	NOT COMPLETED	5 mg Donepezil Hydrochloride	2
Overall Study	NOT COMPLETED	10 mg Donepezil Hydrochloride	6
Overall Study	NOT COMPLETED	Placebo	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00543855/flow